Bristol Myers (Brazil) Top Management

BMYB34 Stock  BRL 355.25  12.45  3.63%   
Bristol Myers employs about 41 people. The company is managed by 10 executives with a total tenure of roughly 14 years, averaging almost 1.0 years of service per executive, having 4.1 employees per reported executive. Analysis of Bristol Myers' management performance can provide insight into the company performance.
Ann Judge  President
Senior Vice President - Global Human Resources
Christopher Boerner  President
Executive Vice President and Chief Commercial Officer
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bristol Myers Squibb. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Bristol Myers Management Team Effectiveness

The company has return on total asset (ROA) of 0.0613 % which means that it generated a profit of $0.0613 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1846 %, meaning that it generated $0.1846 on every $100 dollars invested by stockholders. Bristol Myers' management efficiency ratios could be used to measure how well Bristol Myers manages its routine affairs as well as how well it operates its assets and liabilities.

Bristol Myers Workforce Comparison

Bristol Myers Squibb is number one stock in number of employees category among its peers. The total workforce of Drug Manufacturers - Major industry is currently estimated at about 164,174. Bristol Myers adds roughly 41.0 in number of employees claiming only tiny portion of equities under Drug Manufacturers - Major industry.
The company has Profit Margin (PM) of 0.14 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.2 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.2.

Bristol Myers Squibb Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Bristol Myers Squibb Price Series Summation is a cross summation of Bristol Myers price series and its benchmark/peer.

Bristol Myers Notable Stakeholders

A Bristol Myers stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Bristol Myers often face trade-offs trying to please all of them. Bristol Myers' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Bristol Myers' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Ann JudgeSenior Vice President - Global Human ResourcesProfile
Christopher BoernerExecutive Vice President and Chief Commercial OfficerProfile
Jitendra TyagiHead IndiaProfile
Cari GallmanVP OfficerProfile
David ElkinsEx CFOProfile
BCH BMEx DevelProfile
Giovanni MDChairman CEOProfile
Greg MeyersEx OfficerProfile
Sandra EsqExec CounselProfile
Timothy PowerVP RelationsProfile

About Bristol Myers Management Performance

The success or failure of an entity such as Bristol Myers Squibb often depends on how effective the management is. Bristol Myers management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Bristol management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Bristol management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York. BRISTOLMYERSDRN operates under Drug Manufacturers - Major classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 23300 people.
Please note, the presentation of Bristol Myers' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Bristol Myers' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Bristol Myers' management manipulating its earnings.

Bristol Myers Workforce Analysis

Traditionally, organizations such as Bristol Myers use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Bristol Myers within its industry.

Bristol Myers Manpower Efficiency

Return on Bristol Myers Manpower

Revenue Per Employee1.1B
Revenue Per Executive4.6B
Net Income Per Employee154.3M
Net Income Per Executive632.7M

Complementary Tools for Bristol Stock analysis

When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Equity Valuation
Check real value of public entities based on technical and fundamental data
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk